Derivation and validation of a cardiac risk index in liver transplantation
Derivation and validation of a cardiac risk index in liver transplantation
批准号:
8545595
负责人:
Lisa B VanWagner
金额:
$5.94万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2014-08-31
关键词:
AddressAlgorithmsAwardCalibrationCardiacCardiovascular DiseasesCardiovascular ManifestationCardiovascular systemClinicalClinical DataClinical ManagementClinical ResearchClinical TrialsComorbidityConsensusDataData AnalysesData SourcesDatabasesDecision AnalysisDerivation procedureDevelopmentDiabetes MellitusDiscriminationDisease MarkerEvaluationEventEvidence Based MedicineExpert OpinionFellowshipFutureGoalsGuidelinesHealth Care CostsHealthcareHepatologyHyperlipidemiaHypertensionInstitutesInternal MedicineInvestigationK-Series Research Career ProgramsLifeLiver diseasesMedicalMedicineMentorshipMethodologyMissionModelingMorbidity - disease rateObesityOperative Surgical ProceduresOrgan DonorOrgan ProcurementsOrgan TransplantationOutcomeOutcomes ResearchOutcomes and Health Services ResearchPatientsPerformancePerioperativePeripheral ResistancePhysiologicalPreventive MedicineProceduresProcessPublic HealthRegistriesRelative (related person)Research Project GrantsResource AllocationResourcesRiskRisk AssessmentRisk FactorsSelection BiasStagingStatistical ModelsStratificationTransplant RecipientsTransplantationUniversitiesValidationbasecardiovascular disorder epidemiologycardiovascular disorder riskcardiovascular risk factorcareer developmentchronotropiccost effectivenessdata managementdesignhigh riskimprovedindexingliver transplantationmeetingsmembermortalitymultidisciplinarypatient populationskillsstatisticstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this postdoctoral fellowship is to facilitate the candidate's development as a leader in transplantation outcomes research, with a focus on perioperative cardiovascular (CV) risk assessment. Building on her background in internal medicine, transplant hepatology, and clinical investigation, the candidate proposes to develop additional skills during the award period through (1) coursework designed to expand her methodological skills; (2) interaction with a multidisciplinary team of sponsors and collaborators,
including those in cardiovascular epidemiology, risk assessment, transplantation outcomes, and health services research; and (3) a supervised research project. The overall objective of this project is to define and optimize a preoperative cardiovascular risk assessment model for orthotopic liver transplant (OLT) candidates through two primary specific aims: (1) To determine if a national liver transplant-specific Cardiovascular Risk Index (NOLT-CRI) improves the predictive utility of the commonly used revised cardiac risk index (RCRI) by (1.1) determining the discrimination (C-statistic) and calibration (Hosmer-Lemeshow statistic) of the RCRI as a model of 30-day CV events using secondary data analysis of a national database; and (1.2) comparing the clinical performance of the NOLT-CRI to the RCRI in its ability to reclassify 30-day CV risk and to stratify 1- year survival across the continuum of predicted 30-day CV risk; (2) To determine whether additional variables are needed beyond those available within a national database in order to improve the predictive ability of these models by (2.1) determining the model discrimination and calibration of a locally-derived cardiac risk index (LOLT-CRI) using a center-specific database with more detailed clinical data than are currently available nationally; and (2.2) comparing the clinical performance of the LOLT-CRI to the national models in its ability to reclassify risk. This project will meet the mission of the National Institutes of Healthby identifying cardiovascular disease markers that are unique to the liver transplant candidate, which can then be used to improve pre- and post-transplant medical management in this growing patient population. The project, along with the chosen coursework and mentorship, will allow the candidate to become proficient at data management and statistical methodology. Near the end of the award period, the candidate plans to submit a career development award using the results of the project to develop a cardiovascular risk assessment treatment algorithm for use prior to liver transplantation.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Evaluating elevated bilirubin levels in asymptomatic adults.
评估无症状成人胆红素水平升高。
DOI:
10.1001/jama.2014.12835
发表时间:
2015
期刊:
JAMA
影响因子:
--
作者:
[VanWagner,LisaB, Green,RichardM]
通讯作者:
Green,RichardM
DOI:
10.1016/j.atherosclerosis.2014.05.962
发表时间:
2014-08
期刊:
ATHEROSCLEROSIS
影响因子:
5.3
作者:
[VanWagner, Lisa B., Ning, Hongyan, Lewis, Cora E., Shay, Christina M., Wilkins, John, Carr, J. Jeffrey, Terry, James G., Lloyd-Jones, Donald M., Jacobs, David R., Jr., Carnethon, Mercedes R.]
通讯作者:
Carnethon, Mercedes R.
DOI:
10.1001/jama.2014.302
发表时间:
2014-08-20
期刊:
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
影响因子:
120.7
作者:
[VanWagner, Lisa B., Green, Richard M.]
通讯作者:
Green, Richard M.
Access to retransplantation after failed donation after circulatory death liver transplantation: eo ire itum.
循环死亡肝移植后捐献失败后获得再移植:eo ire itum。
DOI:
10.1111/ajt.12701
发表时间:
2014
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
[Skaro,AI, Zhao,L, Vanwagner,LB, Abecassis,MM]
通讯作者:
Abecassis,MM
DOI:
10.1002/lt.23950
发表时间:
2014-11
期刊:
LIVER TRANSPLANTATION
影响因子:
4.6
作者:
[VanWagner, Lisa B., Lapin, Brittany, Levitsky, Josh, Wilkins, John T., Abecassis, Michael M., Skaro, Anton I., Lloyd-Jones, Donald M.]
通讯作者:
Lloyd-Jones, Donald M.
共 8 条
1/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease
-
批准号:10712618
-
项目类别:
-
资助金额:$42.12万
-
财政年份:2023
-
负责人:Lisa B VanWagner
-
依托单位:
Blood pressure as a modifiable risk factor for cardiovascular events in liver transplant recipients
-
批准号:10838640
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2021
-
负责人:Lisa B VanWagner
-
依托单位:
Blood pressure as a modifiable risk factor for cardiovascular events in liver transplant recipients
-
批准号:10094547
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2021
-
负责人:Lisa B VanWagner
-
依托单位:
Implementation science to improve cardiovascular outcomes among liver transplant recipients
-
批准号:9295465
-
项目类别:
-
资助金额:$18.84万
-
财政年份:2017
-
负责人:Lisa B VanWagner
-
依托单位:
Derivation and validation of a cardiac risk index in liver transplantation
-
批准号:8398068
-
项目类别:
-
资助金额:$6.22万
-
财政年份:2012
-
负责人:Lisa B VanWagner
-
依托单位:
海外基金